NUVL

Conviction 80HealthcareScan · Thu, Jun 25, 2026

Tweezer top

NUVL$123.55-0.02%

ResistanceSupportVol 14Insider sell

Vol MA14 6.99M

Mar 26Apr 14May 1May 19Jun 8Jun 25

Nuvalent, Inc.PHARMACEUTICAL PREPARATIONSwww.nuvalent.com ↗

Price123.55

Change-0.02%

Gap+0.00%

Rel volume0.69×

Avg volume5.34M

Avg $ vol643.13M

SMA 20112.42

SMA 50107.20

SMA 200100.54

Price vs 50+15.26%

Price vs 200+22.88%

MA stackbullish

50/200 cross—

Supertrendup · 115.75

RSI (14)67

MACD hist0.97

MACD cross—

Stoch %K / %D100 / 100

ADX (14)30

+DI / −DI44 / 20

RSI divergence—

MACD divergence—

ATR %+2.54%

ADR %2.67%

52w high123.58

52w low72.16

From 52w high-0.02%

Above 52w low+71.22%

New 52w highYes

SqueezeOff

Bollinger width51.24%

%B0.69

Donchian pos99.62%

Donchian high123.69

Donchian low87.30

AVWAP (52w high)123.57

vs AVWAP high-0.02%

AVWAP (52w low)109.30

vs AVWAP low+13.04%

OBV trendUp

Chaikin MF (20)-0.02

Today vs 20d0.69×

Avg vol (14d)6.99M

Avg vol (20d)5.34M

Avg $ vol (20d)643.13M

Market cap386.64M

RS 3m (vs SPY)+16.27%

RS 6m (vs SPY)+11.32%

RS line new highNo

Trend template8/8

Technical rank84.3

1 week+0.15%

1 month+17.72%

3 months+26.07%

6 months+16.87%

1 year+60.70%

YTD+22.52%

P/E-0.91

P/B0.33

P/S—

P/FCF—

EPS-5.85

Div yield—

ROE-36.22%

ROA-31.96%

Debt/Eq—

Current16.14

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-63.13%

Price target125.18

Target upside1.32%

Analyst ratingHold

Institutional118.32%

Ent. value226.9M

Revenue—

Net income-109.28M

Gross profit—

Free cash flow—

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out73.56M

Employees228

ListedThu, Jul 29, 2021

Free float46.81M

Float %69.6%

Short interest5.24M

Days to cover9.0d

Short volume19.6%

Squeeze score47 / 100

Next earningsThu, Aug 6, 2026 (42d)

EPS forecast−$1.44 · 6 est

Last EPS vs est−$1.39 vs −$1.35

Last surprise-3.0% miss

Setup gradeA

Conviction80 / 100

Pattern quality—

Tech rank84.3 / 100

Group rank50 / 100

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmTweezer top

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in NUVL

All disclosures →

No recent disclosed trades by Congress in NUVL. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in NUVL · 8 buys · 2 sells

Insider	Side	Shares	Value	Traded	Filed
Srivastava Sapna Director · Class A Common Stock · 2026-06-16	Grant	3.44K	—	2026-06-16	2026-06-18
Wheeler Cameron Director · Class A Common Stock · 2026-06-16	Grant	3.44K	—	2026-06-16	2026-06-18
Oliger Christy J. Director · Class A Common Stock · 2026-06-16	Grant	3.44K	—	2026-06-16	2026-06-18
Bogle Grant C. Director · Class A Common Stock · 2026-06-16	Grant	3.44K	—	2026-06-16	2026-06-18
Meyers Michael L. Director · Class A Common Stock · 2026-06-16	Grant	3.44K	—	2026-06-16	2026-06-18
Protopapas Anna Director · Class A Common Stock · 2026-06-16	Grant	3.44K	—	2026-06-16	2026-06-18
Squarer Ron Director · Class A Common Stock · 2026-06-16	Grant	3.44K	—	2026-06-16	2026-06-18
Flynn James E Director · Class A Common Stock · 2026-06-16	Grant	3.44K	—	2026-06-16	2026-06-18
Porter James Richard President and CEO · Class A Common Stock · 2026-06-08	Sell	3.04K	$272K	2026-06-08	2026-06-10
Porter James Richard President and CEO · Class A Common Stock · 2026-06-08	Sell	12.49K	$1.1M	2026-06-08	2026-06-10

SEC filings

EDGAR filings in NUVL · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.